Bio-Rad to Participate at Jefferies 2019 Global Healthcare Conference on June 4
HERCULES, Calif.--(BUSINESS WIRE)--May 23, 2019--
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Ilan Daskal, Executive Vice President and CFO, will participate in Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, at 10 AM (Eastern Time), in New York, NY.
A link to the live webcast of the presentation will be available in the Investor Relations area of our website at www.bio-rad.com.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018. For more information, please visit www.bio-rad.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190523005793/en/
CONTACT: Bio-Rad Laboratories, Inc.
Tina Cuccia, Corporate Communications
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS MEDICAL DEVICES PHARMACEUTICAL RESEARCH SCIENCE
SOURCE: Bio-Rad Laboratories, Inc.
Copyright Business Wire 2019.
PUB: 05/23/2019 04:09 PM/DISC: 05/23/2019 04:09 PM